Search all medical codes
Injection, ranibizumab, 0.1 mg
HCPCS code
Injection, Ranibizumab, 0.1 mg (J2778)
Name of the Procedure:
- Common Name: Eye Injection
- Technical/Medical Term: Injection of Ranibizumab
Summary
Injection of ranibizumab is a procedure where a small amount of medication is injected directly into the eye. It is designed to treat certain eye conditions that can lead to vision loss.
Purpose
- Conditions Addressed: Age-related macular degeneration (AMD), diabetic retinopathy, retinal vein occlusion
- Goals/Outcomes: Reduce vision loss, improve vision by decreasing swelling and preventing the formation of abnormal blood vessels in the retina.
Indications
- Evidence of wet age-related macular degeneration
- Diabetic retinopathy causing macular edema
- Retinal vein occlusion leading to macular edema
- Patients experiencing significant vision loss due to these conditions
Preparation
- Pre-procedure Instructions: No eating or drinking restrictions typically required unless otherwise instructed by your physician. Discontinue certain blood-thinning medications if advised by your doctor.
- Assessments: Eye examination and possibly imaging tests like OCT (Optical Coherence Tomography) to assess the retina.
Procedure Description
- Anesthesia: Numbing drops are applied to the eye to prevent pain.
- Sterilization: The area around the eye is cleaned with an antiseptic solution to reduce infection risk.
- Injection: Using a fine needle, ranibizumab is injected into the vitreous humor (the gel-like substance inside the eye).
- Post-Injection: The eye may be rinsed, and an antibiotic drop may be applied to prevent infection.
Duration
- The actual injection part of the procedure typically takes just a few minutes.
- The entire process, including prep and post-injection care, usually takes 15-30 minutes.
Setting
- The procedure is usually performed in an outpatient clinic or a specialized eye center.
Personnel
- Healthcare Professionals Involved: Ophthalmologist (eye doctor), often assisted by a nurse or medical assistant.
Risks and Complications
- Common Risks: Mild pain, redness, and irritation at the injection site, floaters in vision.
- Rare Risks: Eye infection (endophthalmitis), increased intraocular pressure, retinal detachment, cataract formation.
- Management: Most complications are managed with medication or additional treatments. Severe complications like infection require immediate medical attention.
Benefits
- Expected Benefits: Improvement in vision, slowing or halting progression of vision loss.
- Realization of Benefits: Some patients notice improvements within days to weeks, though it may take longer for others.
Recovery
- Post-Procedure Care: Use prescribed antibiotic eye drops as instructed. Avoid getting water in the eye for a few days.
- Recovery Time: Usually minimal, patients can often resume normal activities within a day, but it's recommended to avoid strenuous activity for a short period.
- Follow-up: Regular follow-up appointments will be necessary to monitor the eye condition and determine if additional injections are needed.
Alternatives
- Other Treatments: Alternative medications (like aflibercept or bevacizumab), laser therapies, photodynamic therapy.
- Pros and Cons: Other medications and treatments may have different efficacy, risks, and cost profiles; it's important to discuss with your doctor to determine the best option for your condition.
Patient Experience
- During the Procedure: Some pressure or discomfort might be felt during the injection, but it should not be painful due to the numbing drops.
- After the Procedure: Mild discomfort or a gritty feeling in the eye, which usually resolves within a day. Vision might be blurry immediately after the injection, but this typically improves. Pain management usually involves OTC pain relievers if necessary.